Recombinant multi-species TAX1BP3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TAX1BP3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a small, highly conserved protein with a single PDZ domain. PDZ (PSD-95/Discs large/ZO-1 homologous) domains promote protein-protein interactions that affect cell signaling, adhesion, protein scaffolding, and receptor and ion transporter functions. The encoded protein interacts with a large number of target proteins that play roles in signaling pathways; for example, it interacts with Rho A and glutaminase L and also acts as a negative regulator of the Wnt/beta-catenin signaling pathway. This protein was first identified as binding to the T-cell leukaemia virus (HTLV1) Tax oncoprotein. Overexpression of this gene has been implicated in altered cancer cell adhesion, migration and metastasis. The encoded protein also modulates the localization and density of inwardly rectifying potassium channel 2.3 (Kir2.3). To date, this protein has been shown to play a role in cell proliferation, development, stress response, and polarization. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Apr 2017]
The Alternative Names of target: 1300011C24Rik,Glutaminase-interacting protein 3,TAX1BP3,TIP-1,TIP1,Tax interaction protein 1 (TIP-1),Tax-interacting protein 1,Tax1-binding protein 3,Tax1bp3
Go
to TAX1BP3 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP7931-Ag-1/ GM-Tg-hg-IP7931-Ag-2 | Human TAX1BP3 protein | Human |
| GM-Tg-rg-IP7931-Ag-1/ GM-Tg-rg-IP7931-Ag-2 | Rat TAX1BP3 protein | Rat |
| GM-Tg-mg-IP7931-Ag-1/ GM-Tg-mg-IP7931-Ag-2 | Mouse TAX1BP3 protein | Mouse |
| GM-Tg-cynog-IP7931-Ag-1/ GM-Tg-cynog-IP7931-Ag-2 | Cynomolgus/Rhesus macaque TAX1BP3 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP7931-Ag-1/ GM-Tg-felg-IP7931-Ag-2 | Feline TAX1BP3 protein | Feline |
| GM-Tg-cang-IP7931-Ag-1/ GM-Tg-cang-IP7931-Ag-2 | Canine TAX1BP3 protein | Canine |
| GM-Tg-bovg-IP7931-Ag-1/ GM-Tg-bovg-IP7931-Ag-2 | Bovine TAX1BP3 protein | Bovine |
| GM-Tg-equg-IP7931-Ag-1/ GM-Tg-equg-IP7931-Ag-2 | Equine TAX1BP3 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP7931-Ag-1/ GM-Tg-hg-IP7931-Ag-2;
GM-Tg-rg-IP7931-Ag-1/ GM-Tg-rg-IP7931-Ag-2;
GM-Tg-mg-IP7931-Ag-1/ GM-Tg-mg-IP7931-Ag-2; GM-Tg-cynog-IP7931-Ag-1/ GM-Tg-cynog-IP7931-Ag-2; GM-Tg-felg-IP7931-Ag-1/ GM-Tg-felg-IP7931-Ag-2; GM-Tg-cang-IP7931-Ag-1/ GM-Tg-cang-IP7931-Ag-2; GM-Tg-bovg-IP7931-Ag-1/ GM-Tg-bovg-IP7931-Ag-2; GM-Tg-equg-IP7931-Ag-1/ GM-Tg-equg-IP7931-Ag-2 |
| Products Name | TAX1BP3 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | TAX1BP3 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TAX1BP3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.